Dr. Natalie Mount FMedSci

Natalie Mount, CEO of Cytospire Therapeutics, is a pioneer in translating novel cell therapies in the UK and is a successful entrepreneur. As founding Chief Scientific Officer at GammaDelta Therapeutics, a spinout from the Crick and Kings College, she led the translation of the academic work into an allogeneic cell therapy manufactured at clinical scale. She later founded Cytospire Therapeutics where her efforts have created new therapeutics leading to clinical trials in cell and gene therapy as well as novel bispecific engagers expected in the clinic. As well as working as an entrepreneur and CEO, she is also a Venture Partner at Abingworth Life Sciences where she focuses on investments in new UK companies.